[go: up one dir, main page]

NO20051521D0 - Anvendelse av kombinasjonen av ciclesonid og antihistaminer for behandlingen av allergisk rhinitt - Google Patents

Anvendelse av kombinasjonen av ciclesonid og antihistaminer for behandlingen av allergisk rhinitt

Info

Publication number
NO20051521D0
NO20051521D0 NO20051521A NO20051521A NO20051521D0 NO 20051521 D0 NO20051521 D0 NO 20051521D0 NO 20051521 A NO20051521 A NO 20051521A NO 20051521 A NO20051521 A NO 20051521A NO 20051521 D0 NO20051521 D0 NO 20051521D0
Authority
NO
Norway
Prior art keywords
ciclesonide
antihistamines
combination
treatment
allergic rhinitis
Prior art date
Application number
NO20051521A
Other languages
English (en)
Other versions
NO335400B1 (no
NO20051521L (no
Inventor
Helgert Mueller
Degenhard Marx
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of NO20051521D0 publication Critical patent/NO20051521D0/no
Publication of NO20051521L publication Critical patent/NO20051521L/no
Publication of NO335400B1 publication Critical patent/NO335400B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20051521A 2002-08-30 2005-03-22 Anvendelse av kombinasjonen av ciclesonid og antihistaminer for behandlingen av allergisk rhinitt NO335400B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02019406 2002-08-30
PCT/EP2003/009622 WO2004019955A1 (en) 2002-08-30 2003-08-29 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis

Publications (3)

Publication Number Publication Date
NO20051521D0 true NO20051521D0 (no) 2005-03-22
NO20051521L NO20051521L (no) 2005-03-22
NO335400B1 NO335400B1 (no) 2014-12-08

Family

ID=31970274

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051521A NO335400B1 (no) 2002-08-30 2005-03-22 Anvendelse av kombinasjonen av ciclesonid og antihistaminer for behandlingen av allergisk rhinitt

Country Status (21)

Country Link
US (2) US7879832B2 (no)
EP (2) EP1545548B1 (no)
JP (2) JP4746318B2 (no)
KR (1) KR101067795B1 (no)
CN (1) CN1674916A (no)
AT (1) ATE472329T1 (no)
AU (1) AU2003273396B2 (no)
BR (2) BR0313611A (no)
CA (1) CA2495830C (no)
DE (1) DE60333205D1 (no)
DK (1) DK1545548T3 (no)
ES (2) ES2393864T3 (no)
IL (1) IL166483A (no)
MX (1) MXPA05001885A (no)
NO (1) NO335400B1 (no)
NZ (1) NZ538954A (no)
PL (1) PL373433A1 (no)
PT (1) PT1545548E (no)
SI (1) SI1545548T1 (no)
WO (1) WO2004019955A1 (no)
ZA (1) ZA200500719B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7879833B2 (en) * 2002-12-12 2011-02-01 Nycomed Gmbh Combination medicament
US8435497B2 (en) * 2003-06-13 2013-05-07 Takeda Gmbh Formoterol of and ciclesonide combination
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
ES2704482T3 (es) 2004-11-24 2019-03-18 Meda Pharmaceuticals Inc Composiciones que comprenden azelastina y sus métodos de uso
WO2006097458A1 (en) * 2005-03-15 2006-09-21 Nycomed Gmbh Novel combination
US20080311196A1 (en) * 2006-07-13 2008-12-18 White Donna F All Day Rhinitic Condition Treatment Regimen
US20080015241A1 (en) * 2006-07-13 2008-01-17 Cornerstone Biopharma, Inc. All day rhinitic condition treatment regimen
JP5661985B2 (ja) 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
KR100878698B1 (ko) * 2007-04-05 2009-01-13 한미약품 주식회사 결정형의 베포타스틴 금속염 수화물, 이의 제조방법 및이를 포함하는 약학 조성물
WO2012048059A2 (en) * 2010-10-06 2012-04-12 Ista Pharmaceuticals, Inc. Bepotastine compositions
US20120323178A1 (en) * 2011-01-04 2012-12-20 Mitsubishi Tanabe Pharma Corporation Bepotastine compositions
BR112015023328A2 (pt) 2013-03-13 2017-07-18 Flatley Discovery Lab compostos de piridazinona e métodos para o tratamento de fibrose cística
CN106692115A (zh) * 2015-11-13 2017-05-24 天津金耀集团有限公司 一种环索奈德混悬鼻喷剂组合物

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (no) 1963-04-24
US3813384A (en) 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
US4369184A (en) 1980-01-24 1983-01-18 Janssen Pharmaceutica N.V. 1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
ATE84968T1 (de) 1987-11-13 1993-02-15 Asta Medica Ag Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge.
GR1001529B (el) 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
RU2132854C1 (ru) 1993-04-02 1999-07-10 Бик Гульден Ломберг Хемише Фабрик ГмбХ Производные преднизолона, способ их получения и лекарственное средство
EP0709099A3 (en) 1994-09-28 1996-07-24 Senju Pharma Co Aqueous suspension for nasal administration containing cyclodextrin
DE19541689A1 (de) 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
AU6290396A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal mast cell stabilizers and topical nasal steroids
WO1997001337A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
EP0780127A1 (en) 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
AU3153797A (en) 1996-06-04 1998-01-05 Procter & Gamble Company, The A nasal spray containing an intranasal steroid and an antihistamine
FR2754712B1 (fr) * 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
US20020111495A1 (en) * 1997-04-04 2002-08-15 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
BR9809022A (pt) 1997-04-30 2000-08-01 Warner Lambert Co Composições antiinflamatórias nasais tópicas
EP0903151A1 (en) 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6297227B1 (en) 1998-09-10 2001-10-02 Schering Corporation Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
US20020061281A1 (en) 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
DE19947234A1 (de) 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
CN1327381A (zh) 1999-10-20 2001-12-19 帝人株式会社 水性药物组合物
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US20040097486A1 (en) 1999-11-18 2004-05-20 Yanni John M. Use of an H1 antagonist and a safe steroid to treat eye conditions
TR200201322T2 (tr) 1999-11-18 2002-11-21 Alcon, Inc. H1 antagonistleri ve güvenli bir steroid'in göz sağlık koşullarının tedavisi için kullanımı
US6653313B2 (en) * 2000-08-10 2003-11-25 Warner-Lambert Company Llc 1,4-dihydropyridine compounds as bradykinin antagonists
US6706726B2 (en) * 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
KR20050044550A (ko) 2001-12-05 2005-05-12 알콘, 인코퍼레이티드 비염 치료를 위한 η1 길항제 및 안전한 스테로이드제의용도
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
WO2004043470A1 (en) 2002-11-12 2004-05-27 Alcon, Inc. The use of an anti-allergy agent and a steroid to treat allergic rhinitis

Also Published As

Publication number Publication date
ATE472329T1 (de) 2010-07-15
BRPI0313611B1 (pt) 2018-03-06
AU2003273396A1 (en) 2004-03-19
DE60333205D1 (de) 2010-08-12
IL166483A0 (en) 2006-01-15
EP1545548B1 (en) 2010-06-30
PL373433A1 (en) 2005-08-22
IL166483A (en) 2013-11-28
SI1545548T1 (sl) 2010-11-30
NO335400B1 (no) 2014-12-08
AU2003273396B2 (en) 2008-12-11
DK1545548T3 (da) 2010-09-27
EP1545548A1 (en) 2005-06-29
JP2011021043A (ja) 2011-02-03
KR101067795B1 (ko) 2011-09-27
CA2495830C (en) 2012-08-21
JP4746318B2 (ja) 2011-08-10
US20050245493A1 (en) 2005-11-03
US8486923B2 (en) 2013-07-16
ES2348034T3 (es) 2010-11-29
EP2295062A1 (en) 2011-03-16
WO2004019955A1 (en) 2004-03-11
CA2495830A1 (en) 2004-03-11
MXPA05001885A (es) 2005-06-03
PT1545548E (pt) 2010-09-02
ZA200500719B (en) 2006-02-22
CN1674916A (zh) 2005-09-28
NZ538954A (en) 2007-04-27
JP2005539044A (ja) 2005-12-22
BR0313611A (pt) 2005-06-21
EP2295062B1 (en) 2012-08-29
NO20051521L (no) 2005-03-22
US7879832B2 (en) 2011-02-01
US20110092471A1 (en) 2011-04-21
ES2393864T3 (es) 2012-12-28
KR20050058400A (ko) 2005-06-16

Similar Documents

Publication Publication Date Title
NO20051521L (no) Anvendelse av kombinasjonen av ciclesonid og antihistaminer for behandlingen av allergisk rhinitt
DE60231295D1 (de) R und ppar modulatoren
DE60322582D1 (de) Oberflächenbehandlung von medizinischem gerät
DE60237725D1 (de) Vervendung von dexrazoxane in der prävention und behandlung der alzeheimer-krankheit
DE60229922D1 (de) Kombinationen, ein antidiarrhoikum und epothilon oder ein epothilonderivat enthaltend
CY2014031I1 (el) Τροποποιημενα 2’ και 3’-νουκλεοζιτικα προφαρμακα για θεραπεια μολυνσεων απο flaviviridae
EE05417B1 (et) Epotilooni analoogide ja kemoterapeutikumide kombinatsiooni kasutamine teraapias
DE60328797D1 (de) Blutbehandlungsgerät
DE602004023503D1 (de) Medizinisches behandlungswerkzeug und dieses entha
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
NO20051692L (no) Anvendelse av indolylderivater for fremstilling av et medikament for behandling av allergisk rhinitt
ATE534391T1 (de) 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen
NO20052009D0 (no) Kombinasjonsterapi for behandling av akutt leukumi og myelodysplastikksyndrom
NO20062694L (no) Inhibitor av mutant form av KIT
NO20053623D0 (no) Derivater av prostaglandiner for behandling av abdominalt ubehag
ATE469886T1 (de) 17beta-hydroxysteroid dehydrogenase typ-3 hemmer zur behandlung von androgen abhängigen erkrankungen
DK1553950T3 (da) Terapeutisk behandling
DE60224004D1 (de) Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten
DE60233740D1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
NO20043445L (no) Kombinasjonsterapi for behandling av bakterielle infeksjoner
NO20052264D0 (no) Pregahalinderivater for behandling av fibromyalgi og andre forstyrrelser
NO20035043D0 (no) Fremgangsmåte for behandling av okular hypertensjon og glaukom
DK1601352T3 (da) Kombineret anvendelse af et fibrat og orlistat til behandling af fedme
ATE359270T1 (de) Phenyl-piperidin-4-yliden-methyl-benzamidderiva e zur behandlung von schmerz oder magen-darm- erkrankungen
NO20053247L (no) Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt.

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ASTRAZENECA AB, SE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: COVIS PHARMA B.V., CH

CREP Change of representative

Representative=s name: BRYN AARFLOT AS, STORTINGSGATA 8, 0161 OSLO, NORGE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: COVIS PHARMA GMBH, CH

MK1K Patent expired